← Leaderboards
Lu Dai
Univ Of Arkansas For Med Scis
$795,513
Attributed
$795,513
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $491.5K · FY2022–25$500K$375K$250K$125K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$795,513 · 3
By mechanism
R03$610,000 · 2
R21$185,513 · 1
Top collaborators
No co-investigators on record.
Most similar at Univ Of Arkansas For Med Scis
Same institution · by research overlap
- Robert L Eoff$4,489,303
- Mark Manzano$1,915,360
- Marjan Boerma$10,067,143
Others in their field
Other Rising Stars on “Therapeutically Effective”
- Rebecca Montalvan · Westat, Inc.$86,600,000
- Sabrina Paganoni · Massachusetts General Hospital$26,348,733
- Suma Babu · Massachusetts General Hospital$26,348,733
- Supriya Menezes · The Emmes Company, Llc$18,394,958
- Daniel Hunter Reirden · Westat, Inc.$15,038,020
- Cynthia M Visness · Rho Federal Systems Division, Inc.$14,006,776
Research focus
Therapeutically EffectiveVirus Related CancerOrgan Transplant RecipientProteinsTumor TissueNeoplastic CellHuman Herpesvirus 8IncidenceLinkPrimary Effusion LymphomaMalignant NeoplasmsTumorEffective TherapyMouse ModelAnti-CancerHigh RiskAcquired Immunodeficiency SyndromeImmunocompromised HostIn VivoCombination Drug TherapyKaposi SarcomaPathogenesisEtiologyXenograft Procedure
Grant awards (4)
Role of Macrophage Migration Inhibitory Factor (MIF) in KSHV-associated Malignancies$306,000
R03 · FY2025 · DE · contact PI
Development of OâPROTACs-based degraders targeting an oncogenic viral protein$185,513
R21 · FY2025 · AI · contact PI
Targeting ILlRAP in virus-associated malignancies$152,000
R03 · FY2023 · DE · contact PI
Targeting ILlRAP in virus-associated malignancies$152,000
R03 · FY2022 · DE · contact PI